Recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India - followup report.
作者信息
Malaviya Anand N, Kapoor Sanjiv, Garg Shriram, Rawat Roopa
出版信息
J Rheumatol. 2010 Jan;37(1):209. doi: 10.3899/jrheum.090854.
PMID:20040648
Abstract
摘要
相似文献
1
Recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India - followup report.
J Rheumatol. 2010 Jan;37(1):209. doi: 10.3899/jrheum.090854.
2
Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
J Rheumatol. 2009 Jul;36(7):1414-20. doi: 10.3899/jrheum.081042. Epub 2009 Jun 1.
3
Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
J Rheumatol. 2010 Mar;37(3):672-3; author reply 673. doi: 10.3899/jrheum.090672.
4
Tuberculosis associated with therapy against tumor necrosis factor alpha.
Arthritis Rheum. 2005 Oct;52(10):2968-74. doi: 10.1002/art.21382.
5
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
Pneumologie. 2009 Jun;63(6):329-34. doi: 10.1055/s-0029-1214673. Epub 2009 Jun 10.
6
Tumor necrosis factor-alpha blocker induced tuberculosis.
J Rheumatol. 2010 Jul;37(7):1542; author reply 1543. doi: 10.3899/jrheum.100058.
7
Making tumor necrosis factor blockers safer: a prescriber's consumptive challenge.
J Rheumatol. 2008 Jul;35(7):1238-9. Epub 2008 Jun 15.
8
Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
J Rheumatol. 2008 Jul;35(7):1271-6. Epub 2008 Mar 15.
9
Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
J Rheumatol. 2009 Mar;36(3):546-51. doi: 10.3899/jrheum.080854. Epub 2009 Feb 17.
10
[Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
Ann Dermatol Venereol. 2006 May;133(5 Pt 2):1S8-12.
Zotero 插件